GeneDx Holdings Goodwill and Intangible Assets 2020-2023 | WGS
GeneDx Holdings goodwill and intangible assets from 2020 to 2023. Goodwill and intangible assets can be defined as the sum of all intangible asset fields
| GeneDx Holdings Annual Goodwill and Intangible Assets (Millions of US $) |
|
|---|---|
| 2023 | $173 |
| 2022 | $187 |
| 2021 | $ |
| 2020 | $ |
| 2019 | $0 |
| GeneDx Holdings Quarterly Goodwill and Intangible Assets (Millions of US $) |
|
|---|---|
| 2023-12-31 | $173 |
| 2023-09-30 | $176 |
| 2023-06-30 | $180 |
| 2023-03-31 | $183 |
| 2022-12-31 | $187 |
| 2022-09-30 | $372 |
| 2022-06-30 | $375 |
| 2022-03-31 | |
| 2021-12-31 | |
| 2021-09-30 | |
| 2021-06-30 | |
| 2021-03-31 | |
| 2020-12-31 | |
| 2020-09-30 | $0 |
| 2019-12-31 | $0 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.510B | $0.203B |
| GeneDx Holdings Corp. is at the forefront of transforming healthcare through its industry-leading exome and genome testing and interpretation, fueled by rare disease data sets. GeneDx Holdings Corp., formerly known as Sema4 Holdings Corp., is based in STAMFORD, Conn. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $123.165B | 15.45 |
| Cencora (COR) | United States | $44.692B | 17.42 |
| ICON (ICLR) | Ireland | $25.998B | 24.54 |
| DiDi Global (DIDIY) | China | $24.302B | 0.00 |
| Avantor (AVTR) | United States | $16.893B | 24.87 |
| CochLear (CHEOY) | Australia | $14.118B | 0.00 |
| Viatris (VTRS) | United States | $14.074B | 4.05 |
| Revvity (RVTY) | United States | $12.701B | 22.25 |
| Medpace Holdings (MEDP) | United States | $12.416B | 40.85 |
| Charles River Laboratories (CRL) | United States | $12.119B | 22.09 |
| Natera (NTRA) | United States | $11.739B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $11.436B | 0.00 |
| Solventum (SOLV) | United States | $11.160B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $8.373B | 0.00 |
| HealthEquity (HQY) | United States | $6.801B | 50.81 |
| Organon (OGN) | United States | $5.318B | 5.04 |
| Bausch + Lomb (BLCO) | Canada | $5.074B | 20.34 |
| Doximity (DOCS) | United States | $4.589B | 34.17 |
| PACS (PACS) | United States | $3.743B | 0.00 |
| Surgery Partners (SGRY) | United States | $3.254B | 30.12 |
| Sotera Health (SHC) | United States | $3.196B | 15.68 |
| Progyny (PGNY) | United States | $3.114B | 52.26 |
| GoodRx Holdings (GDRX) | United States | $2.951B | 149.40 |
| Life Times (LTH) | United States | $2.907B | 30.79 |
| Premier (PINC) | United States | $2.483B | 9.09 |
| AMN Healthcare Services Inc (AMN) | United States | $2.270B | 7.34 |
| Teladoc Health (TDOC) | United States | $2.169B | 0.00 |
| Agilon Health (AGL) | United States | $1.985B | 0.00 |
| BrightSpring Health Services (BTSG) | United States | $1.955B | 0.00 |
| NovoCure (NVCR) | Jersey | $1.673B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.493B | 0.00 | |
| Agiliti (AGTI) | United States | $1.368B | 22.33 |
| Alignment Healthcare (ALHC) | United States | $1.296B | 0.00 |
| Pediatrix Medical (MD) | United States | $0.780B | 8.07 |
| QDM (QDMI) | Hong Kong, SAR China | $0.703B | 18.40 |
| Embecta (EMBC) | United States | $0.598B | 3.95 |
| InnovAge Holding (INNV) | United States | $0.587B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.533B | 0.00 |
| CareDx (CDNA) | United States | $0.527B | 0.00 |
| LifeMD (LFMD) | United States | $0.509B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.497B | 0.00 |
| Enhabit (EHAB) | United States | $0.495B | 44.82 |
| Sonida Senior Living (SNDA) | United States | $0.449B | 0.00 |
| MultiPlan (MPLN) | United States | $0.429B | 0.00 |
| Beauty Health (SKIN) | United States | $0.423B | 0.00 |
| DocGo (DCGO) | United States | $0.385B | 61.67 |
| ModivCare (MODV) | United States | $0.381B | 7.12 |
| Sera Prognostics (SERA) | United States | $0.322B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.267B | 0.00 |
| Sharecare (SHCR) | United States | $0.261B | 0.00 |
| Biodesix (BDSX) | United States | $0.174B | 0.00 |
| So-Young (SY) | China | $0.128B | 43.00 |
| Oncology Institute (TOI) | United States | $0.070B | 0.00 |
| Pono Capital Two (PTWO) | United States | $0.069B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.054B | 0.00 |
| NeueHealth (NEUE) | United States | $0.051B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.039B | 0.00 |
| Nutex Health (NUTX) | United States | $0.033B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.033B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.032B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.030B | 0.00 |
| OncoCyte (OCX) | United States | $0.023B | 0.00 |
| DermTech (DMTK) | United States | $0.022B | 0.00 |
| BIMI Holdings (BIMI) | United States | $0.013B | 0.00 |
| Aesthetic Medical Hldngs Group (AIH) | China | $0.013B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.011B | 0.00 | |
| TRxADE HEALTH (MEDS) | United States | $0.009B | 0.00 |
| XWELL (XWEL) | United States | $0.008B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
| OpGen (OPGN) | United States | $0.006B | 0.00 |
| NewGenIvf Group (NIVF) | Singapore | $0.004B | 0.00 |
| Assure Holdings (IONM) | United States | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |